You haven't searched anything yet.
About Aura:
At Aura, our mission is to develop a new class of oncology targeted therapies that deliver meaningful therapeutic benefit to a range of cancer indications with high unmet need in which we believe we can establish a new standard of care. We are driven by our passion and commitment to science and the patients battling cancer who are relying on us to pioneer these new therapies.
We are focusing the initial development of our VDC technology platform to treat tumors of high unmet need in ocular and urologic oncology. AU-011, our first VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. Beyond primary choroidal melanoma, we are developing AU-011 in additional ocular oncology indications, including choroidal metastases. Leveraging our VDCs’ broad tumor targeting capabilities, we also plan to initiate a clinical program in non-muscle invasive bladder cancer, or NMIBC, our first non-ophthalmic solid tumor indication.
Position Summary:
Reporting to the Upstream Process Development Lead, the (Sr) Associate Scientist will be responsible for the development of upstream production processes and the production of material for routine in-house development use. This includes all assays associated with cell culture production. The incumbent will also participate in the transfer of the upstream process to support biopharmaceutical product development at Contract Manufacturing Organizations (CMOs). The scientist will interact with the in-house team and the CRO/CMO to ensure timely progress in technology development, documentation, and manufacturing readiness.
Responsibilities include but are not limited to:
Process development:
Technology Development and Continuous Improvement:
Tech Transfer:
Manufacturing Support:
Other projects as assigned by management.
Minimum Requirements:
Desired Qualifications
Full Time
$151k-185k (estimate)
02/25/2024
04/03/2024
aurabiosciences.com
Cambridge, MA
<25